•  
  •  
  •  
  •  

2025-10-07 19:35:26

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain

Keywords Selected:  INE285J01028

Stock Report

  • SIS Limited allots NCDs for Rs. 250 crores
  • SIS Invests ₹10.16 Crores in Age Care Labs to leapfrog into B2C Segment and move up the value chain of Facility Management Services
  • SIS Ltd to invest in Agarsha Senior Care Pvt Ltd
  • SIS to be the official private security provider to the Ram Mandir Trust in Ayodhya
  • SIS Ltd to invest in Entitled Solutions Pvt Ltd
  • SIS Ltd announces INR 80 cr. Buyback of equity shares
  • SIS Limited board approves buyback through tender offer route
  • SIS Limited to appoint ex-SEBI chairman U K Sinha as additional independent director
  • SIS Limited to invest in Staqu Technologies
  • SIS wins Rs. 225 crores contract from Mahanadi Coalfields
  • SIS Australia Group Pty Ltd completes acquisition of 49% in P4G

Latest Post

  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024